Login / Signup

METTL14 plays an oncogenic role in NSCLC by modulating ferroptosis and the m6A modification of GPX4.

Yang LouKan HuangBo XuXianguo Chen
Published in: Archives of physiology and biochemistry (2024)
The METTL14/GPX4 axis promotes NSCLC progression by inhibiting cell ferroptosis through the recognition of m6A modification mediated by IGF2BP1.
Keyphrases